Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) has been integral in transforming endoscopic GI practice from just an imaging model to more of an interventional tool. Beginning with the initial reports of EUS-FNA being used in 1992, it has been part of a protocol ever since in diagnosing and staging algorithms for evaluating benign and malignant diseases of the Gl tract (and adjacent organs). EUS-FNA and FNB have been seen as major breakthroughs in technology in their ability to provide definitive evidence of a malignancy.

Provide details to continue

  • Your information will be protected in accordance with our privacy statement.

The site needs to use cookies to store information in your web browser, to make this site work. By clicking “Submit” you consent to the placement of these cookies. Learn more about our cookie policy.